CD34 and Hodgkins lymphoma: In contrast, 10 additional patients with Hodgkin lymphoma with higher CD34 dose, had a shorter median time to achieve these endpoints (16 days (range 13–22) for Platelet20 and 19 days (range 16–42) for Platelet50).